FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns a liquid formulation of a long-acting conjugate of granulocyte colony stimulating factor (G-CSF) containing a therapeutically effective amount of the long-acting conjugate of granulocyte colony stimulating factor wherein G-CSF is covalently bond to immunoglobulin Fc fragment by a non-peptide polymer, and an albumin-free stabilising agent containing a buffer and mannitol.
EFFECT: invention makes the long-acting conjugates of G-CSF having better duration of action and stability in vivo, stay storage-stable for a long period of time.
24 cl, 1 dwg, 16 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITION OF LONG-ACTING ALPHA INTERFERON CONJUGATE | 2011 |
|
RU2613905C2 |
| LIQUID FORMULATIONS FOR LONG-ACTING ERYTHROPOIETIN CONJUGATE | 2011 |
|
RU2682720C2 |
| LIQUID COMPOSITION OF HUMAN GROWTH HORMONE WITH PROLONGED ACTION | 2011 |
|
RU2623026C2 |
| LIQUID COMPOSITION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE | 2013 |
|
RU2643766C2 |
| LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE | 2013 |
|
RU2670270C2 |
| SUSTAINED TYPE HUMAN GROWTH HORMONE PREPARATION | 2014 |
|
RU2683823C2 |
| LIQUID FORMULATION OF LONG-ACTING INSULINOTROPIC PEPTIDE CONJUGATE | 2013 |
|
RU2671576C2 |
| STABLE LIQUID COMPOSITION OF FUSED PROTEIN WITH DOMAIN Fc IgG | 2016 |
|
RU2688679C1 |
| PROTEIN COMPLEX, OBTAINED BY USING FRAGMENT OF IMMUNOGLOBULIN, AND METHOD OF SUCH COMPLEX OBTAINING | 2004 |
|
RU2356909C2 |
| PHARMACEUTICAL COMPOSITION OF FUSION PROTEIN TACI-FC | 2020 |
|
RU2779387C1 |
